The Role of the Private Sector in the European Market

리서치사	HBS Consulting
발행일	2006년 06월	상품코드	40488
페이지 정보
가격	US $ 4,450 ￦ 5,302,100 MS Word file by E-mail (Single User License) US $ 4,450 ￦ 5,302,100 PDF by E-mail (Single User License) US $ 4,500 ￦ 5,361,700 Hard Copy

한글목차
영문목차
관련자료

영문목차

Abstract

This latest strategic publication from HBS Consulting provides an overview of the changes taking place in the European private healthcare sector which will have a bearing on development of business and marketing strategies of medical devices and diagnostic manufactures. The report,

examines the trends in private healthcare provision and financing in key EU markets. Additionally, the two largest of the new EU member states - Hungary and Poland - are included
provides an overview of the main corporate players in the respective European markets
highlights some of the challenges and opportunities for manufacturers of medical devices and diagnostics in the emerging private healthcare sector
assesses some of the lessons which might be learned from studying the US model for healthcare provision

1 EXECUTIVE SUMMARY

2 INTRODUCTION

2.1 Models of Healthcare Systems in Europe
- 2.1.1 Role of Private Medical Insurance
- 2.1.2 Role of Private Providers
  - 2.1.2.1 Leading Providers
2.2 The Funding Conundrum
- 2.2.1 The Dutch Model
2.3 Escalating Costs of Healthcare Services and Technology
2.4 Private Medical Insurance Increasing
2.5 Role of MedTech/Healthcare Companies in Healthcare Provision

3 THE PRIVATE SECTOR'S ROLE IN KEY EU MARKETS

3.1 FRANCE
- 3.1.1 French Health System and the Private Sector
- 3.1.2 Private Providers
- 3.1.3 Private Medical Insurance
- 3.1.4 Market Dynamics
3.2 GERMANY
- 3.2.1 German Health System & the Private Sector
- 3.2.2 Private Providers
- 3.2.3 Private Medical Insurance
- 3.2.4 Market Dynamics
3.3 ITALY
- 3.3.1 Italian Health System and the Private Sector
- 3.3.2 Private Providers
- 3.3.3 Private Medical Insurance
- 3.3.4 Market Dynamics
3.4 SPAIN
- 3.4.1 Spanish Health System & the Private Sector
- 3.4.2 Private Providers
- 3.4.3 Private Medical Insurance
- 3.4.4 Market Dynamics
3.5 UK
- 3.5.1 UK Health System and the Private Sector
- 3.5.2 Private Providers
- 3.5.3 Private Medical Insurance
- 3.5.4 Market Dynamics
3.6 Focus on Major New EU Markets
- 3.6.1 HUNGARY
  - 3.6.1.1 Hungarian Health System and the Private Sector
  - 3.6.1.2 Private Providers
  - 3.6.1.3 Private Medical Insurance
  - 3.6.1.4 Market Dynamics
- 3.6.2 POLAND
  - 3.6.2.1 Polish Health System and the Private Sector
  - 3.6.2.2 Private Providers
  - 3.6.2.3 Private Medical Insurance
  - 3.6.2.4 Market Dynamics

4 MEDTECH PURCHASING BY PRIVATE PURCHASERS

4.1 Key Decision-Makers
4.2 Factors Influencing Purchasing Decisions
4.3 Purchasing Mechanisms
4.4 Group Purchasing
- 4.4.1 The German Experience
4.5 Sales & Marketing Strategies
4.6 Leasing

5 THE US MODEL: LESSONS FOR EUROPE

5.1 US Healthcare System
- 5.1.2 Sources of Healthcare Funding
- 5.1.3 Private Healthcare Insurance
  - 5.1.3.1 Managed Care
  - 5.1.3.2 Trends in Employer-Sponsored Health Insurance
  - 5.1.3.3 Individual Health Insurance
- 5.1.4 Universal Access Remains Elusive
5.2 The US vs Europe: Impact on MedTech
5.3 Learning from the US Model
- 5.3.1 GPOs: The US Experience
  - 5.3.1.1 GPOs: Lessons for Europe
- 5.3.2 Managed Care
  - 5.3.2.1 The UK Experience
    - 5.3.2.1.1 The Kaiser Model
    - 5.3.2.1.2 The Evercare Programme
- 5.3.3 Health Technology Assessment
  - 5.3.3.1 Key Lessons